Literature DB >> 14515163

Changes in GSH-antioxidant system induced by daunorubicin in human normal and diabetic fibroblasts.

Agnieszka Zatorska1, Janusz Maszewski, Zofia Jóźwiak.   

Abstract

We investigated the effect of daunorubicin on glutathione content and activity of GSH-related enzymes in cultured normal and diabetic human fibroblasts. Cells were incubated with 4 microM daunorubicin (DNR) for 2 h followed by culture in drug-free medium for up to 72 h. Treatment of diabetic cells with the drug caused a time-dependent depletion of intracellular GSH and a decrease of the GSH to total glutathione ratio. GSH depletion was accompanied by apoptotic changes in morphology of the nucleus. Analysis of GSH-related enzymes showed a significant increase of the activities of Se-dependent and Se-independent peroxidases and glutathione S-transferase. In contrast, glutathione reductase activity was reduced by 50%. Significant differences between normal and diabetic cells exposed to DNR were observed in the level of GST and Se-dependent glutathione peroxidase activities. These findings indicated that daunorubicin efficiently affects the GSH antioxidant defense system both in normal and diabetic fibroblasts leading to disturbances in glutathione content as well as in the activity of GSH-related enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515163     DOI: 035003825

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  2 in total

1.  The induction of apoptosis by daunorubicin and idarubicin in human trisomic and diabetic fibroblasts.

Authors:  Sylwia Dragojew; Agnieszka Marczak; Janusz Maszewski; Krzysztof Ilnicki; Zofia Jóźwiak
Journal:  Cell Mol Biol Lett       Date:  2008-04-10       Impact factor: 5.787

2.  The Relation between Polymorphisms in Exon 5 and Exon 6 of GSTP1 Gene and the Risk of Lung Cancer in Iranian People

Authors:  Gholamreza Shahsavari; Ali Amiri; Masoud Shamaei; Glavizh Adibhesami; Amirnader Emami Razavi; Mehdi Birjandi; Mihan Pourabdollah
Journal:  Asian Pac J Cancer Prev       Date:  2019-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.